What is the Fiscal Year for BriaCell Therapeutics?
Date: November 13, 2026
BriaCell Therapeutics's current fiscal year starts on August 1, 2026, and ends on July 31, 2027. Their current quarter is Q2, which ends on January 31, 2027.
Current Fiscal Year Overview
Fiscal Year Start
August 1, 2026
Fiscal Year End
July 31, 2027
Current Quarter
Q2
Current Quarter End
January 31, 2027
Quarterly Breakdown
Q1
Aug 1, 2026 – Oct 31, 2026
Q2
Nov 1, 2026 – Jan 31, 2027
Q3
Feb 1, 2027 – Apr 30, 2027
Q4
May 1, 2027 – Jul 31, 2027
Company Information
Headquarters
Philadelphia, Pennsylvania
Industry
Biotechnology Research
Stock Symbol
BCTX
Website
https://briacell.comDescription
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like BriaCell Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.